Meyka AI API is live for developers.Start building.
Advertisement
Rein Therapeutics Inc.

Rein Therapeutics Inc. (RNTX) Stock Overview

Explore Rein Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

RNTX●NASDAQ
HealthcareMedical - Pharmaceuticals
$0.94
$0.08(7.54%)
U.S. Market opens in 52h 36m
Advertisement

Rein Therapeutics Inc. (RNTX)

Meyka AI Score

Z

Key Financials

Market Cap26.4M
P/E Ratio-0.57
EPS (TTM)$-1.90
ROE-2.58%
Fundamental Analysis

AI Price Forecasts

1 Month$1.45
3 Months$1.15
1 Year Target$0.70

RNTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Rein Therapeutics Inc. (RNTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.78, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.70.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.57 and a market capitalization of 26.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.54%
5-Day Change
-15.04%
1-Month Change
-7.54%
3-Month Change
-20.75%
6-Month Change
-30.65%
Year-to-Date (YTD) Change
-18.70%
1-Year Change
-51.64%
3-Year Change
-55.51%
5-Year Change
-55.51%
All-Time (Max) Change
-55.51%

Contact Information

http://www.reintx.com
737 802 1989
12407 N. Mopac Expy., Austin, TX, 78758

Company Facts

11 Employees
IPO DateJun 29, 2017
CountryUS
Actively Trading

Frequently Asked Questions